Does IDELALISIB Cause Therapy non-responder? 39 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Therapy non-responder have been filed in association with IDELALISIB (Zydelig). This represents 0.6% of all adverse event reports for IDELALISIB.
39
Reports of Therapy non-responder with IDELALISIB
0.6%
of all IDELALISIB reports
1
Deaths
3
Hospitalizations
How Dangerous Is Therapy non-responder From IDELALISIB?
Of the 39 reports, 1 (2.6%) resulted in death, 3 (7.7%) required hospitalization, and 2 (5.1%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IDELALISIB. However, 39 reports have been filed with the FAERS database.
What Other Side Effects Does IDELALISIB Cause?
Disease progression (1,204)
Death (779)
Diarrhoea (752)
Off label use (548)
Pneumonia (426)
Pyrexia (371)
Drug ineffective (294)
Fatigue (284)
Dehydration (242)
Dyspnoea (206)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which IDELALISIB Alternatives Have Lower Therapy non-responder Risk?
IDELALISIB vs IDURSULFASE
IDELALISIB vs IFOSFAMIDE
IDELALISIB vs IGURATIMOD
IDELALISIB vs ILOPERIDONE
IDELALISIB vs ILOPROST